"Company","Parent Company","Penalty Amount","Subtraction From Penalty","Penalty Amount Adjusted For Eliminating Multiple Counting","Penalty Year","Penalty Date","Offense Group","Primary Offense","Secondary Offense","Description","Level of Government","Action Type","Agency","Civil/Criminal","Prosecution Agreement","Court","Case ID","Private Litigation Case Title","Lawsuit Resolution","Facility State","City","Address","Zip","NAICS Code","NAICS Translation","HQ Country of Parent","HQ State of Parent","Ownership Structure","Parent Company Stock Ticker","Major Industry of Parent","Specific Industry of Parent","Info Source","Notes"
"Amyris, Inc.","Amyris","$300,000","$0","$300,000","2021","20211015","financial offenses","investor protection violation","","","federal","agency action","Securities and Exchange Commission","civil","","","","","","","","","","","","USA","California","publicly traded","AMRS","pharmaceuticals","biotechnology","https://www.sec.gov/litigation/admin/2021/34-93341.pdf",""
